These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors. Razzaghi-Asl N, Firuzi O, Hemmateenejad B, Javidnia K, Edraki N, Miri R. Bioorg Med Chem; 2013 Nov 15; 21(22):6893-909. PubMed ID: 24113238 [Abstract] [Full Text] [Related]
23. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles. Hook VY, Toneff T, Aaron W, Yasothornsrikul S, Bundey R, Reisine T. J Neurochem; 2002 Apr 15; 81(2):237-56. PubMed ID: 12064471 [Abstract] [Full Text] [Related]
30. Crystallization of glycosylated human BACE protease domain expressed in Trichoplusia ni. Wang W, Reichert P, Beyer BM, Liu JJ, Lee J, Zhang L, Liu YH, Taremi SS, Le HV, Strickland C. Biochim Biophys Acta; 2004 May 06; 1698(2):255-9. PubMed ID: 15134659 [Abstract] [Full Text] [Related]
31. Fetzima (levomilnacipran), a drug for major depressive disorder as a dual inhibitor for human serotonin transporters and beta-site amyloid precursor protein cleaving enzyme-1. Rizvi SM, Shaikh S, Khan M, Biswas D, Hameed N, Shakil S. CNS Neurol Disord Drug Targets; 2014 May 06; 13(8):1427-31. PubMed ID: 25345508 [Abstract] [Full Text] [Related]
33. Development and characterization of a novel membrane assay for full-length BACE-1 at pH 6.0. Saric A, Brügge Lz, Müller-Pompalla D, Rysiok T, Ousson S, Permanne B, Quattropani A, Busch M, Beher D, Hussain I. J Biomol Screen; 2013 Mar 06; 18(3):277-85. PubMed ID: 23023105 [Abstract] [Full Text] [Related]